Malin Corporation plc (MLC.IR)
EUR 8.7
(0.0%)
EUR 8.7
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.5 Million EUR | -133.09% |
| 2022 | 13.6 Million EUR | 1071.43% |
| 2021 | -1.4 Million EUR | 58.82% |
| 2020 | -3.4 Million EUR | 75.71% |
| 2019 | -14 Million EUR | 45.31% |
| 2018 | -25.6 Million EUR | 59.17% |
| 2017 | -62.7 Million EUR | -11.57% |
| 2016 | -56.2 Million EUR | -23.52% |
| 2015 | -45.5 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -700.00 EUR | 39.13% |
| 2024 Q2 | -700.00 EUR | 0.0% |
| 2023 Q2 | -1100.00 EUR | 0.0% |
| 2023 Q1 | -1100.00 EUR | 46.34% |
| 2023 Q4 | -1150.00 EUR | -35.29% |
| 2023 Q3 | -850.00 EUR | 22.73% |
| 2023 FY | -3.9 Million EUR | -128.68% |
| 2022 Q1 | 400.00 EUR | 0.0% |
| 2022 Q2 | 400.00 EUR | 0.0% |
| 2022 Q3 | -2050.00 EUR | -612.5% |
| 2022 Q4 | -2050.00 EUR | 0.0% |
| 2022 FY | 13.6 Million EUR | 1071.43% |
| 2021 Q2 | -1100.00 EUR | 0.0% |
| 2021 FY | -1.4 Million EUR | 58.82% |
| 2021 Q1 | -1100.00 EUR | -46.67% |
| 2020 Q1 | -1200.00 EUR | 74.19% |
| 2020 FY | -3.4 Million EUR | 75.71% |
| 2020 Q4 | -750.00 EUR | 70.59% |
| 2020 Q2 | -1200.00 EUR | 0.0% |
| 2020 Q3 | -2550.00 EUR | -112.5% |
| 2019 Q1 | -2350.00 EUR | 65.19% |
| 2019 Q4 | -4650.00 EUR | 0.0% |
| 2019 Q2 | -2350.00 EUR | 0.0% |
| 2019 FY | -14 Million EUR | 45.31% |
| 2019 Q3 | -4650.00 EUR | -97.87% |
| 2018 Q2 | -4500.00 EUR | 0.0% |
| 2018 Q3 | -6750.00 EUR | -50.0% |
| 2018 Q4 | -6750.00 EUR | 0.0% |
| 2018 FY | -25.6 Million EUR | 59.17% |
| 2018 Q1 | -4500.00 EUR | 59.28% |
| 2017 FY | -62.7 Million EUR | -11.57% |
| 2017 Q4 | -11.05 Thousand EUR | 0.0% |
| 2017 Q3 | -11.05 Thousand EUR | 4.74% |
| 2017 Q2 | -11.6 Thousand EUR | 0.0% |
| 2017 Q1 | -11.6 Thousand EUR | 16.85% |
| 2016 Q1 | -9300.00 EUR | 99.95% |
| 2016 FY | -56.2 Million EUR | -23.52% |
| 2016 Q4 | -13.95 Thousand EUR | 0.0% |
| 2016 Q3 | -13.95 Thousand EUR | -50.0% |
| 2016 Q2 | -9300.00 EUR | 0.0% |
| 2015 FY | -45.5 Million EUR | 0.0% |
| 2015 Q2 | -11.07 Million EUR | 0.0% |
| 2015 Q1 | -11.07 Million EUR | 0.0% |
| 2015 Q4 | -20.3 Million EUR | -83.3% |
| 2015 Q3 | -11.07 Million EUR | 0.0% |
| 2014 Q4 | -11.07 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AB Science S.A. | -13.42 Million EUR | 66.49% |
| Boiron SA | 42.29 Million EUR | 110.641% |
| Fagron NV | 105.44 Million EUR | 104.268% |
| Ipsen S.A. | 816 Million EUR | 100.551% |
| Vetoquinol SA | 74.26 Million EUR | 106.059% |